人民财讯8月27日电，唯赛勃(688718)8月27日晚间披露半年报，2025年上半年，公司实现营业收入为 1.85亿元，同比增长0.27%；归母净利润1501.11万元，同比下降19.30%；基本每股收益0.09元。公司拟 向全体股东每10股派发现金红利1.16元(含税)。报告期内，归属于上市公司股东的净利润同比降低，主 要原因是公司新增厂房和设备计提折旧。 ...

上海唯赛勃新材料股份有限公司2025 年半年度报告 公司代码：688718 公司简称：唯赛勃 上海唯赛勃新材料股份有限公司 2025 年半年度报告 1 / 172 上海唯赛勃新材料股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人谢建新、主管会计工作负责人孙桂萍及会计机构负责人（会计主管人员）孙桂 萍声明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 2025 年 8 月 27 日，第五届董事会第二十三次会议审议通过《关于公司 2025 年半年度利润 分配方案的议案》，公司拟以实施权益分派股权登记日登记的总股本扣减公司回购专用证券账户 中股份为基数,向全体股东每 10 股派发现金红利 1.16 元（含税）。截至本公告披露日，公司总 股本 173,754,389 股，扣减回购专用证券账户中股份总数 90 ...

Core Insights - The company reported a revenue of 185 million yuan for the first half of 2025, representing a year-on-year growth of 0.27% [1] - The net profit for the same period was 15.01 million yuan, showing a decline of 19.30% compared to the previous year [1] Financial Performance - Revenue: 185 million yuan, up 0.27% year-on-year [1] - Net Profit: 15.01 million yuan, down 19.30% year-on-year [1]

Group 1 - The total margin financing balance of the Sci-Tech Innovation Board increased by 4.98 billion yuan, with a total balance of 2026.42 billion yuan as of August 21, marking a continuous increase for 29 trading days [1][2] - The highest margin financing balance is held by SMIC at 9.088 billion yuan, followed by Cambrian and Haiguang Information with balances of 6.823 billion yuan and 5.351 billion yuan respectively [1][2] - A total of 322 stocks saw an increase in margin financing balance, while 262 stocks experienced a decrease [1] Group 2 - The highest margin short-selling balance is held by Cambrian at 0.33 billion yuan, followed by Haiguang Information and SMIC with balances of 0.29 billion yuan and 0.21 billion yuan respectively [2] - 118 stocks saw an increase in margin short-selling balance, while 156 stocks experienced a decrease [2] - The stocks with the largest increases in margin short-selling balance include Kaisa Bio, Weigao Orthopedics, and Lexin Technology, with increases of 97.37%, 91.21%, and 85.81% respectively [2]

Group 1 - A new company named Zhejiang Guoyuan Weisaibo New Materials Co., Ltd. has been established with a registered capital of 10 million yuan [1] - The business scope of the company includes the sale of synthetic materials and the manufacturing of automotive parts and components [1] - The company is jointly held by Weisaibo and other stakeholders according to the equity penetration data from Qichacha [1]

Group 1 - The company has changed its name from "Shanghai Weisaibo Environmental Technology Co., Ltd." to "Shanghai Weisaibo New Materials Co., Ltd." [1] - The English name remains "Wave Cyber (Shanghai) Co., Ltd." and the stock abbreviation "Weisaibo" with the stock code "688718" remains unchanged [1] - The name change was approved by the company's board and shareholders, and the necessary business registration procedures have been completed [1] Group 2 - The company has obtained a new business license from the Shanghai Municipal Market Supervision Administration reflecting the name change [1] - The registered capital of the company is RMB 173.754389 million [1] - The company was established on August 28, 2001, and is located at No. 899 Songying Road, Qingpu District, Shanghai [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码：688718 证券简称：唯赛勃 公告编号：2025-021 上海唯赛勃新材料股份有限公司 关于公司名称变更完成工商变更登记的公告 成立日期：2001 年 08 月 28 日 住所：上海市青浦区崧盈路 899 号 经营范围：设计和生产水处理设备及其相关配套零部件，销售自产产品，并 提供产品技术服务。（依法须经批准的项目，经相关部门批准后方可开展经营活 特此公告。 上海唯赛勃新材料股份有限公司（以下简称"公司"）于 2024 年 12 月 3 日召开第五届董事会第十九次会议，审议通过《关于拟变更公司全称的议案》， 同意将公司中文全称由"上海唯赛勃环保科技股份有限公司"变更为"上海唯赛 勃新材料股份有限公司"。英文全称 "Wave Cyber(Shanghai)Co., Ltd. "，证券 简称"唯赛勃"，证券代码"688718"保持不变。上述事项已经公司 2024 年第 三次临时股东会审议通过。具体内容详见公司于 2024 年 12 月 4 日在上海证券交 易所网站（w ...

二、董事会会议审议情况 （一）审议通过《关于注销前次境外投资的议案》 公司拟于 2017 年向美国子公司进行增资，后因资金需求及安排发生变化， 该项目投资未能落实到位。截止目前，公司自 2017 年 6 月取得的该项《企业境 外投资证书》已失效，现申请注销前次境外投资。 证券代码：688718 证券简称：唯赛勃 公告编号：2025-020 上海唯赛勃环保科技股份有限公司 第五届董事会第二十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载，误导性陈 述或者重大遗漏，并对其内容的真实性，准确性和完整性依法承担法律责任。 一、董事会会议召开情况 2025 年 6 月 27 日，上海唯赛勃环保科技股份有限公司（以下简称"公司"） 以现场会议的方式召开了第五届董事会第二十二次会议。本次会议通知及相关 材料公司已于 2025 年 6 月 17 日以专人和通讯等方式送达各位董事。本次会议 由公司董事长谢建新先生主持，会议应出席董事 6 人，实际出席董事 6 人。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律 法规、部门规章、规范性文件和《上海唯赛勃环保科技股份有限公司章程》（以 ...

证券代码：688718 证券简称：唯赛勃 公告编号：2025-019 上海唯赛勃环保科技股份有限公司 关于对外投资设立合资公司暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 司，开展气体分离膜产品的研发、生产和销售，实现多方的战略合作及优势互补。 合资公司注册资本 1,000 万元，公司以自有资金出资 510 万元，占比 51%；上海 咫荟以自有资金出资 150 万元，占比 15%；天津智汇以知识产权和专业技能入股， 占比 34%。因公司高管樊智锋先生为上海咫荟的控股股东，故本次投资涉及关联 交易。 （二）本次交易的目的和背景 气体膜分离采用通过膜表面选择性渗透的概念，用于从不同直径的气体混合 物中分离气体，与其他气体分离技术相比，具有资本成本低、寿命长、能耗低等 优势。作为一种高效、节能的气体分离技术，气体膜分离广泛应用于氧气分离、 氮气回收、碳捕集、工业气体处理等能源、化工、医疗、环保等领域。得益于能 源与化工需求驱动、全球环保政策推动、产业升级需求、应用领域拓展等因素， 气体分离膜市场正处于快速发展 ...

Overview of the Investment and Related Transactions - Shanghai Weisaibo Environmental Technology Co., Ltd. plans to jointly invest with Tianjin Zhihui Membrane Technology Research Co., Ltd. and Shanghai Zhihui Management Partnership (Limited Partnership) to establish a joint venture named "Shanghai Weisaibo Zhihui Membrane Technology Development Co., Ltd." with a registered capital of 10 million yuan [1][2] - The company will contribute 5.1 million yuan, accounting for 51% of the joint venture, while Shanghai Zhihui will contribute 1.5 million yuan (15%), and Tianjin Zhihui will contribute through intellectual property and professional skills, accounting for 34% [1][2] Purpose and Background of the Investment - The joint venture aims to develop, produce, and sell gas separation membrane products, leveraging strategic cooperation and complementary advantages among the partners [2] - Gas membrane separation technology is recognized for its low capital costs, long lifespan, and low energy consumption, making it suitable for various applications in energy, chemicals, medical, and environmental sectors [2][3] - The global gas separation membrane market is experiencing rapid growth, driven by energy and chemical demands, global environmental policies, and industrial upgrades, with significant potential in the Chinese market [2] Company and Partner Profiles - The company has over 20 years of experience in high-performance membrane technology, focusing on research and application, and has established a comprehensive innovation system from basic formulation research to industrial production [3] - Tianjin Zhihui is backed by a leading research platform at Tianjin University, led by renowned experts in membrane materials, which will enhance the joint venture's technological and market capabilities [3] Related Party Transactions - The investment constitutes a related party transaction due to the involvement of the company's vice president, who is the controlling shareholder of Shanghai Zhihui [3][4] - The independent directors and the board's audit committee have approved the investment, confirming it aligns with the interests of the company and all shareholders [6][7] Impact of the Investment - Establishing the joint venture is expected to expand the company's product offerings, enhance competitiveness, and create new economic growth points, contributing to long-term value [7] - The funding for the investment will come from the company's own resources and will not significantly impact its financial status or operational results [7]